Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma

Fangyi Gu, Abrar A. Qureshi, Tianhua Niu, Peter Kraft, Qun Guo, David J. Hunter, Jiali Han

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Genetic variation in immune-regulating components such as cytokines may lead to interindividual differences in immunosuppression response and susceptibility to melanoma. We evaluated the associations between genetic variants in five interleukins (IL) and IL receptor genes (IL-4, IL-4R, IL-6, IL-6R, and IL-10) and the risk of melanoma. Twenty-five single nucleotide polymorphisms (SNPs) were selected that are functionally relevant or tagging SNPs of each gene. We conducted a nested case-control study of 219 female patients and 219 matched controls within the Nurses' Health Study. We observed that in the IL-6R gene, four SNPs in linkage disequilibrium were associated with an increased risk of melanoma. Three are located in introns (rs6684439, rs4845618, and rs4845622), and one is a nonsynonymous SNP in exon 9 [rs8192284 (Asp358Ala)]. An elevated risk of melanoma was observed in the heterozygous groups of these SNPs with odds ratio of 1.74 [(95% confidence interval, 1.07, 2.81) for rs6684439, 1.72 (1.04, 2.84) for rs4845618, 1.69 (1.03, 2.75) for rs4845622, and 1.68 (1.04, 2.73) for rs8192284]. But these associations were not observed in the homozygous variant group with odds ratios ranging from 0.93 to 1.03. We did not find significant results for the SNPs in the other four genes. These data suggest the involvement of IL-6R in melanoma development. Further studies are needed to confirm these findings.

Original languageEnglish (US)
Pages (from-to)330-335
Number of pages6
JournalMelanoma Research
Volume18
Issue number5
DOIs
StatePublished - Oct 1 2008
Externally publishedYes

Fingerprint

Interleukin Receptors
Interleukins
Single Nucleotide Polymorphism
Melanoma
Genes
Odds Ratio
Linkage Disequilibrium
Interleukin-4
Interleukin-10
Immunosuppression
Introns
Case-Control Studies
Exons
Interleukin-6
Nurses
Confidence Intervals
Cytokines
Health

Keywords

  • Interleukin receptors
  • Interleukins
  • Melanoma
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Oncology
  • Dermatology
  • Cancer Research

Cite this

Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. / Gu, Fangyi; Qureshi, Abrar A.; Niu, Tianhua; Kraft, Peter; Guo, Qun; Hunter, David J.; Han, Jiali.

In: Melanoma Research, Vol. 18, No. 5, 01.10.2008, p. 330-335.

Research output: Contribution to journalArticle

Gu, Fangyi ; Qureshi, Abrar A. ; Niu, Tianhua ; Kraft, Peter ; Guo, Qun ; Hunter, David J. ; Han, Jiali. / Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. In: Melanoma Research. 2008 ; Vol. 18, No. 5. pp. 330-335.
@article{a8f1c9765e724f61b1bbf69f50c2b103,
title = "Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma",
abstract = "Genetic variation in immune-regulating components such as cytokines may lead to interindividual differences in immunosuppression response and susceptibility to melanoma. We evaluated the associations between genetic variants in five interleukins (IL) and IL receptor genes (IL-4, IL-4R, IL-6, IL-6R, and IL-10) and the risk of melanoma. Twenty-five single nucleotide polymorphisms (SNPs) were selected that are functionally relevant or tagging SNPs of each gene. We conducted a nested case-control study of 219 female patients and 219 matched controls within the Nurses' Health Study. We observed that in the IL-6R gene, four SNPs in linkage disequilibrium were associated with an increased risk of melanoma. Three are located in introns (rs6684439, rs4845618, and rs4845622), and one is a nonsynonymous SNP in exon 9 [rs8192284 (Asp358Ala)]. An elevated risk of melanoma was observed in the heterozygous groups of these SNPs with odds ratio of 1.74 [(95{\%} confidence interval, 1.07, 2.81) for rs6684439, 1.72 (1.04, 2.84) for rs4845618, 1.69 (1.03, 2.75) for rs4845622, and 1.68 (1.04, 2.73) for rs8192284]. But these associations were not observed in the homozygous variant group with odds ratios ranging from 0.93 to 1.03. We did not find significant results for the SNPs in the other four genes. These data suggest the involvement of IL-6R in melanoma development. Further studies are needed to confirm these findings.",
keywords = "Interleukin receptors, Interleukins, Melanoma, Single nucleotide polymorphism",
author = "Fangyi Gu and Qureshi, {Abrar A.} and Tianhua Niu and Peter Kraft and Qun Guo and Hunter, {David J.} and Jiali Han",
year = "2008",
month = "10",
day = "1",
doi = "10.1097/CMR.0b013e32830658b2",
language = "English (US)",
volume = "18",
pages = "330--335",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma

AU - Gu, Fangyi

AU - Qureshi, Abrar A.

AU - Niu, Tianhua

AU - Kraft, Peter

AU - Guo, Qun

AU - Hunter, David J.

AU - Han, Jiali

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Genetic variation in immune-regulating components such as cytokines may lead to interindividual differences in immunosuppression response and susceptibility to melanoma. We evaluated the associations between genetic variants in five interleukins (IL) and IL receptor genes (IL-4, IL-4R, IL-6, IL-6R, and IL-10) and the risk of melanoma. Twenty-five single nucleotide polymorphisms (SNPs) were selected that are functionally relevant or tagging SNPs of each gene. We conducted a nested case-control study of 219 female patients and 219 matched controls within the Nurses' Health Study. We observed that in the IL-6R gene, four SNPs in linkage disequilibrium were associated with an increased risk of melanoma. Three are located in introns (rs6684439, rs4845618, and rs4845622), and one is a nonsynonymous SNP in exon 9 [rs8192284 (Asp358Ala)]. An elevated risk of melanoma was observed in the heterozygous groups of these SNPs with odds ratio of 1.74 [(95% confidence interval, 1.07, 2.81) for rs6684439, 1.72 (1.04, 2.84) for rs4845618, 1.69 (1.03, 2.75) for rs4845622, and 1.68 (1.04, 2.73) for rs8192284]. But these associations were not observed in the homozygous variant group with odds ratios ranging from 0.93 to 1.03. We did not find significant results for the SNPs in the other four genes. These data suggest the involvement of IL-6R in melanoma development. Further studies are needed to confirm these findings.

AB - Genetic variation in immune-regulating components such as cytokines may lead to interindividual differences in immunosuppression response and susceptibility to melanoma. We evaluated the associations between genetic variants in five interleukins (IL) and IL receptor genes (IL-4, IL-4R, IL-6, IL-6R, and IL-10) and the risk of melanoma. Twenty-five single nucleotide polymorphisms (SNPs) were selected that are functionally relevant or tagging SNPs of each gene. We conducted a nested case-control study of 219 female patients and 219 matched controls within the Nurses' Health Study. We observed that in the IL-6R gene, four SNPs in linkage disequilibrium were associated with an increased risk of melanoma. Three are located in introns (rs6684439, rs4845618, and rs4845622), and one is a nonsynonymous SNP in exon 9 [rs8192284 (Asp358Ala)]. An elevated risk of melanoma was observed in the heterozygous groups of these SNPs with odds ratio of 1.74 [(95% confidence interval, 1.07, 2.81) for rs6684439, 1.72 (1.04, 2.84) for rs4845618, 1.69 (1.03, 2.75) for rs4845622, and 1.68 (1.04, 2.73) for rs8192284]. But these associations were not observed in the homozygous variant group with odds ratios ranging from 0.93 to 1.03. We did not find significant results for the SNPs in the other four genes. These data suggest the involvement of IL-6R in melanoma development. Further studies are needed to confirm these findings.

KW - Interleukin receptors

KW - Interleukins

KW - Melanoma

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=53549134937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53549134937&partnerID=8YFLogxK

U2 - 10.1097/CMR.0b013e32830658b2

DO - 10.1097/CMR.0b013e32830658b2

M3 - Article

C2 - 18781131

AN - SCOPUS:53549134937

VL - 18

SP - 330

EP - 335

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 5

ER -